Higher PBX1 transcription scores were associated with better total survival, whereas the decreased expression of PBX1 was associated with poor VHL mutation prognosis in ccRCC, which may be related to the molecular heterogeneity of the VHL-mutant ccRCC subgroup (Wang et al., 2022b). Here, PBX1 is linked to nonpapillary renal cell carcinoma.